Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Revance Therapeutics Inc. buy RudolfL

Start price
€4.86
04.02.24 / 0%
Target price
-
04.02.25
Performance (%)
13.17%
End price
€5.50
04.03.24
Summary
This prediction ended on 04.03.24 with a price of €5.50. The BUY prediction by RudolfL finished with a performance of 13.17%. This prediction was marked as speculative and is excluded from RudolfL's performance statistics.
Performance without dividends (%)
Name 1w 1m
Revance Therapeutics Inc. - -
iShares Core DAX® -1.215% 4.788%
iShares Nasdaq 100 -1.911% 1.109%
iShares Nikkei 225® -3.171% 5.626%
iShares S&P 500 -1.029% 1.792%

Comments by RudolfL for this prediction

In the thread Revance Therapeutics Inc. diskutieren

Buy Revance Therapeutics Inc.

In the thread Trading Revance Therapeutics Inc.
Prediction Buy
Perf. (%) 13.17%
Target price
Change
Ends at 04.02.25

Buy beendet